A clearer measure
of neurological
function.

A summary score can compress differences in timing, consistency, and how a response changes across repeated attempts. Cerebro is investigating whether studying those relationships adds useful information beyond individual measurements. That added value must be demonstrated, not assumed.A summary score can compress differences in timing, consistency, and how a response changes across repeated attempts. Cerebro is investigating whether studying those relationships adds useful information beyond individual measurements. That added value must be demonstrated, not assumed.▌A summary score can compress differences in timing, consistency, and how a response changes across repeated attempts. Cerebro is investigating whether studying those relationships adds useful information beyond individual measurements. That added value must be demonstrated, not assumed.

Eye-movement tasks let researchers examine how someone finds a target, follows movement, or responds to a changing instruction. Cerebro studies these responses alongside other functional domains. An eye-movement measurement alone does not establish a diagnosis.Eye-movement tasks let researchers examine how someone finds a target, follows movement, or responds to a changing instruction. Cerebro studies these responses alongside other functional domains. An eye-movement measurement alone does not establish a diagnosis.▌Eye-movement tasks let researchers examine how someone finds a target, follows movement, or responds to a changing instruction. Cerebro studies these responses alongside other functional domains. An eye-movement measurement alone does not establish a diagnosis.

Dynamic Response Behavior (DRB) describes how neurocognitive responses unfold over time—how they adapt to task demands, vary across repeated attempts, and relate across ocular, vestibular, reaction-time, cognitive, and motor domains. It guides our research; it is not a validated clinical score or diagnostic finding.Dynamic Response Behavior (DRB) describes how neurocognitive responses unfold over time—how they adapt to task demands, vary across repeated attempts, and relate across ocular, vestibular, reaction-time, cognitive, and motor domains. It guides our research; it is not a validated clinical score or diagnostic finding.▌Dynamic Response Behavior (DRB) describes how neurocognitive responses unfold over time—how they adapt to task demands, vary across repeated attempts, and relate across ocular, vestibular, reaction-time, cognitive, and motor domains. It guides our research; it is not a validated clinical score or diagnostic finding.

Ocular, vestibular, reaction-time, cognitive, and motor tasks offer different ways to observe neurological function. Our hypothesis is that relationships between their responses may reveal information that separate measurements miss. More measurements do not automatically mean better assessment; their added value needs evidence.Ocular, vestibular, reaction-time, cognitive, and motor tasks offer different ways to observe neurological function. Our hypothesis is that relationships between their responses may reveal information that separate measurements miss. More measurements do not automatically mean better assessment; their added value needs evidence.▌Ocular, vestibular, reaction-time, cognitive, and motor tasks offer different ways to observe neurological function. Our hypothesis is that relationships between their responses may reveal information that separate measurements miss. More measurements do not automatically mean better assessment; their added value needs evidence.

First, measurements must be reliable and reproducible. Then prospective studies must test performance in the intended population, against appropriate reference standards, and establish whether the combined signals add value over existing assessment. Our literature review explains the research rationale and its limits; it does not establish clinical validation of Neocognitron.First, measurements must be reliable and reproducible. Then prospective studies must test performance in the intended population, against appropriate reference standards, and establish whether the combined signals add value over existing assessment. Our literature review explains the research rationale and its limits; it does not establish clinical validation of Neocognitron.▌First, measurements must be reliable and reproducible. Then prospective studies must test performance in the intended population, against appropriate reference standards, and establish whether the combined signals add value over existing assessment. Our literature review explains the research rationale and its limits; it does not establish clinical validation of Neocognitron.

Neocognitron is investigational. It is not cleared for diagnosis or independent treatment, disposition, or return-to-activity decisions. We welcome conversations about research collaboration; clinical use requires evidence for a defined intended use and the appropriate regulatory pathway.Neocognitron is investigational. It is not cleared for diagnosis or independent treatment, disposition, or return-to-activity decisions. We welcome conversations about research collaboration; clinical use requires evidence for a defined intended use and the appropriate regulatory pathway.▌Neocognitron is investigational. It is not cleared for diagnosis or independent treatment, disposition, or return-to-activity decisions. We welcome conversations about research collaboration; clinical use requires evidence for a defined intended use and the appropriate regulatory pathway.